Concepedia

Publication | Closed Access

Regression of Advanced Ovarian Carcinoma by Intraperitoneal Treatment With Autologous TLymphocytes Retargeted by a Bispecific Monoclonal Antibody

DOI

191

Citations

0

References

1995

Year

Silvana Canevari, Gerrit Stoter, Flavio Arienti, Giorgio Bolis, M. I. Colnaghi, Emanuela M. Di Re, Alexander M. M. Eggermont, S.H. Goey, J.W. Gratama, C. B. H. W. Lamers,
JNCI Journal of the National Cancer Institute

Abstract

Improvement in systemic antitumor responses is needed before this approach can prove useful as adjunctive treatment following induction chemotherapy in patients with minimal residual disease.